News

New research finds half-cardio, half-strength training reduces cardiovascular disease risks

17 Jan: New research finds half-cardio, half-strength training reduces cardiovascular disease risks

Structured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aerobic exercise alone or combined aerobic plus resistance exercise, but not resistance exercise alone, improved CVD risk profile (composite Z-score) compared with no-exercise control (Z-score values below 0 indicate favorable changes in CVD risk

How vaccines that target specific forms of cancer are showing great promise

17 Jan: How vaccines that target specific forms of cancer are showing great promise

Mansoor Amiji, University Distinguished Professor in the Departments of Pharmaceutical Sciences and Chemical Engineering at Northeastern. Credit: Matthew Modoono/Northeastern University One of the great promises in the field of cancer immunotherapy is the emergence of cancer vaccines. Unlike traditional vaccines that are tailored to infectious diseases, cancer vaccines work by teaching the immune system to

14 Jan: Transcranial Electrical Stimulation Effective for Insomnia

TOPLINE: Transcranial alternating current stimulation (tACS), a noninvasive technique that uses low-intensity electrical currents to modulate brain activity, is an effective intervention for treating chronic insomnia, especially in older people, results of a relatively large study suggested. METHODOLOGY: The double-blind study included 124 adults with chronic insomnia (difficulty falling asleep or maintaining sleep and early

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

31 Dec: Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, according to a study published online Nov. 27 in eClinicalMedicine. Fumiki Yoshihara, from the National Cerebral and Cardiovascular Center in Osaka, Japan, and colleagues conducted a multicenter, randomized trial that enrolled

29 Dec: tDCS Promising for Improved Cognition in Alzheimer’s

TOPLINE: Transcranial direct current stimulation (tDCS) delivered twice daily over 6 weeks can improve cognitive function in patients with Alzheimer’s disease (AD), highlighting the potential of tDCS as a therapeutic intervention, new research shows.  METHODOLOGY: The study enrolled 124 patients with mild to moderate AD, with 63 randomly allocated to receive active tDCS and 61